Intervention
Topiramate
ClinicalTrials.gov intervention label
Explore related research
Search across original and mapped recordsSearch results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 20 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
20 shownPharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric SurgeryNCT05975580 · 2023-08-29
RECRUITINGStudying Topiramate for Re-Activating the HIV-1 ReservoirNCT06282783 · 2024-09-01
UNKNOWNAnti-obesity Pharmacotherapy and InflammationNCT05756764 · 2023-06-01
ACTIVE_NOT_RECRUITINGTopiramate vs Metformin on Cardio-Metabolic Profile in Schizophrenia on Atypical AntipsychoticsNCT05663749 · 2022-09-20
COMPLETEDMedications After Adolescent Bariatric SurgeryNCT04572217 · 2022-06-01
WITHDRAWNTopiramate and Severe ObesityNCT02273804 · 2016-06-01
COMPLETEDTopiramate and Schizophrenia: Effects on Weight and PsychopathologyNCT02808533 · 2016-05-01
ACTIVE_NOT_RECRUITINGPharmacovigilance in Gerontopsychiatric PatientsNCT02374567 · 2015-01-01
TERMINATEDTreatment of Obesity With Topiramate in Patients With Polycystic Ovary SyndromeNCT04453306 · 2014-05-01
UNKNOWNTopiramate in Adolescents With Severe ObesityNCT01859013 · 2013-06-01
COMPLETEDTopiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's DiseaseNCT01789047 · 2013-03-01
TERMINATEDTopiramate to Reduce Heavy Drinking in HIV-Positive Heavy DrinkersNCT01764685 · 2013-01-01
TERMINATEDStudy of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 WeeksNCT02810483 · 2012-12-01
TERMINATEDDrug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With ObesityNCT01351753 · 2011-03-01
TERMINATEDQuantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's DiseaseNCT00794313 · 2009-09-01
TERMINATEDTopiramate for the Treatment of Alcohol Dependent Binge-Eating Disordered IndividualsNCT00300742 · 2006-03-01
COMPLETEDRelationship Between Topiramate Use and Ocular Angle StatusNCT00153699 · 2004-09-01
UNKNOWNTreatment of Self-Injurious Behavior in Individuals With Prader-Willi SyndromeNCT00065923 · 2002-07-01
COMPLETEDA Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I DisorderNCT00035802 · 2002-01-01
COMPLETEDA Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral PolyneuropathyNCT00231673 · 2001-07-01
COMPLETEDCommon conditions
Obesity5Alcohol Dependence2Hiv2Prader-Willi Syndrome2Schizophrenia2Affective Disorders, Psychotic1Anxiety Disorders1Binge Eating1Bipolar Disorder1Dementia1Depression1Diabetes Mellitus, Type 21Diabetic Neuropathies1Drug Induced Dyskinesia1Glaucoma, Angle-Closure1Heavy Drinking1HIV I Infection1HIV Infections1HIV-1-infection1Hyperandrogenism1Idiopathic Parkinson's Disease1Mental Disorders1Metabolic Syndrome1Metabolic Syndrome X1Mood Disorders1
Mapped diseases appearing in these trials
Shared study participation does not establish that this intervention treats a disease.
obesity disorder5alcohol dependence2Prader-Willi syndrome2schizophrenia2abdominal obesity-metabolic syndrome1binge eating disorder1bipolar disorder1dementia1depressive disorder1drug-induced dyskinesia1metabolic syndrome X1morbid obesity1Parkinson disease1polycystic ovary syndrome1type 2 diabetes mellitus1
Leading sponsors
Assistance Publique - Hôpitaux de Paris
2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
2
All India Institute of Medical Sciences, Bhubaneswar
1
Centre for Addiction and Mental Health
1
Chinese University of Hong Kong
1
Erasmus Medical Center
1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
1
Hannover Medical School
1
Hospital de Clinicas de Porto Alegre
1
Janey Pratt
1
Louisiana State University Health Sciences Center in New Orleans
1
Oregon Health and Science University
1
Rush University Medical Center
1
University of California, Irvine
1
University of Iowa
1
Trial status mix
COMPLETED7
TERMINATED6
UNKNOWN3
ACTIVE_NOT_RECRUITING2
RECRUITING1
WITHDRAWN1
Phase mix
PHASE28
PHASE34
PHASE44
NA3
PHASE11
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.